Krystal Biotech, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Krystal Biotech, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2024.
- Krystal Biotech, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 29.9M shares, a 3.5% increase year-over-year.
- Krystal Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 27.8M shares, a 8.87% increase from 2022.
- Krystal Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 25.5M shares, a 14.8% increase from 2021.
- Krystal Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 22.2M shares, a 18.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)